Abstract
The modifying action of ascorbic acid (AA) on endogenous formation of NNitroso compounds is well known. We have studied the action of AA on the mortality of rats due to hepatoma induced by N-nitrosodiethylamine (NDEA) and on the activity of some marker enzymes of hepatocarcinogenesis. AA (50 mg per animal intraperitoneally three times a week during three months) accelerated the NDEA induced hepatocarcinogenesis. In the NDEA group one rat died after 400 days, in the NDEA+AA group 11 rats (P<0.01). At later stages the mortality difference of both groups was less distinct. The macroscopic grading of hepatomas in necropsied rats of the NDEA+AA group was significantly higher (grade 4.41) than in the NDEA only group (grade 3.09, P<0.02). Administration of AA augmented the increase of activity of glucose-6-phosphate dehydrogenase and the decrease of the activity of glucose-6-phosphatase compared with activities in the NDEA group. The activity of hexokinase, pyruvate kinase and glucose-6-phosphate dehydrogenase in the liver increased in the NDEA+AA group much earlier than in the NDEA group. The accelerating action of high doses of AA on nitrosamine hepatocarcinogenesis has to be taken into account in cancer chemoprevention and treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Doll, R. and Peto, R. (1981) J. Natl. Cancer Inst. 66, 1191–1308
Mirvish, S.S. (1986) Cancer 58, 1842–1850
Nair, J., Nair, U.J., Ohshima, H., Bhide, S.V., Bartsch, H. (1987) in Relevance of N-nitroso compounds to human cancer: Exposures and mechanism. IARC Sci. Publ., 84, p. 465–469
Fukushima, S., Imaida, R., Sakata, T., Okamura, T., Shibata, M. and Ito, N. (1983) Cancer Res., 43, 4454–4457
Cameron, E., Pauling, L., Leibovitz, B. (1979) Cancer Res. 39, 663–681
Moertel, C.C., Fleming, T.R., Creagan, E.T., Rubin, J., O’Connel, M.J. and Ames M.M. (1985) N. Engl. J. Med. 312, 137–141
Ton, C.C.T., Fong, L.Y.Y. (1984) Carcinogenesis 5, 533–536
Mirvish, S.S. (1981) in Inhibition of tumor induction and development. (eds M.S. Zedeck and M. Lipkin) Plenum Press, NY a. London, pp. 101–126
Peto, R., Pike M.C., Day, N.E., Gray, R.G., Lee, P.N., Parish, S., Peto, J., Richards, S., Wahrendorf, J. in Long-term and short-term screening assays for carcinogens: a critical appraisal. IARC Monographs, suppl. 2.–Lyon, 1980 pp. 311–426
Gurkalo. V.K., Zabezhinski, M.A. (1982) Neoplasma 29, 301–307
Zannoni, V.G., Holsztynska, E.G., Lau, S.S. (1982) in Ascorbic Acid: Chemistry, Metabolism and Uses. 2nd Chem. Congr. N. Amer. Contin. Washington, D.C., pp. 349–368
Omaye, S.T., Turnbull, J.D. (1980) Life Sci. 27, 441–449
Rikans, L.E. (1982) J. Pharmacol. Exp. Ther. 204, 702–713
Horio, F., Ozaki, K., Kohmura, M., Yoshida, A., Makino S. and Hayashi, Y. (1986) J. Nutr., 116, 2278–2289
Rubenchik, B.L., Juchimenko, M.D., Boim, T.M., Mihhailenko, V.M. (1988) Eksperimentalnaya Onkologiya (Russ.) 10, 29–32
Diaz-Gomez, M.I., Swann, P.F., Magee, P.N. (1977) Biochem. J., 164, 497–500
Keeman T.H., Weinkaro, R.T. (1985) Toxicol. and Appl. Pharmacol. 78, 316–320
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Bogovski, P., Birk, R., Kildema, L., Teras, L. (1989). Modification of Nitrosamine Carcinogenesis by Ascorbic Acid. In: Garner, R.C., Hradec, J. (eds) Biochemistry of Chemical Carcinogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0539-2_24
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0539-2_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7856-6
Online ISBN: 978-1-4613-0539-2
eBook Packages: Springer Book Archive